SCHEMBL5482662

SCHEMBL5482662

CCOc1cc2c(cc1OC)C(c1ccc(C(=O)O)cc1)=NC1CCC(OC(C)=O)CC21

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 8/20 0.57
PDE4A P27815 7/20 0.57
PDE4B Q07343 6/20 0.57
PDE4C Q08493 6/20 0.57
TSHR P16473 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
SSTR5 P35346 1/20 0.35
PDGFRB P09619 1/20 0.35
PDGFRA P16234 1/20 0.35
CHEK1 O14757 1/20 0.35
LMNA P02545 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34
MEN1 O00255 1/20 0.34
CHRM1 P11229 1/20 0.34
KMT2A Q03164 1/20 0.34
PDE3A Q14432 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3471184 0.95 PDE4D (0.49) PDE4DPDE4APDE4BPDE4CTSHR
Hydrochloric Acid SCHEMBL3470610 0.94 PDE4D (0.48) PDE4DPDE4APDE4BPDE4CTSHR
SCHEMBL6386857 0.93 PDE4D (0.55) PDE4DPDE4APDE4BPDE4CTSHR
SCHEMBL5481132 0.92 PDE4D (0.48) PDE4DPDE4APDE4BPDE4CTSHR
SCHEMBL5477358 0.91 PDE4B (0.49) PDE4DPDE4APDE4BPDE4CTSHR
SCHEMBL2346855 0.90 PDE4D (0.51) PDE4DPDE4APDE4BPDE4CKDM4E
SCHEMBL2346530 0.89 PDE4D (0.47) PDE4DPDE4APDE4BPDE4CTSHR
SCHEMBL1411271 0.88 PDE4D (0.49) PDE4DPDE4APDE4BPDE4CKDM4E
SCHEMBL3470263 0.88 PDE4D (0.46) PDE4DPDE4APDE4BPDE4CPDGFRB
SCHEMBL2271405 0.88 PDE4D (0.49) PDE4DPDE4APDE4BPDE4CKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185149-A1 Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibtors ALTANA PHARMA AG (DE) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185149-A1 Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibtors PDE4A, PDE4B, PDE4C PDE4D 4/4885PDE4A 1/4885PDE4B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.